Generate a tailored SOP for Dr. Jennifer Cooperrider. Improve your application with a focused, well-structured draft.
Jennifer Cooperrider, MD, is an Assistant Professor in the Biological Sciences Division at the University of Chicago, focusing on research in hematology and oncology. Her work primarily investigates the neurocognitive toxicity associated with intrathecal chemotherapy and the effectiveness of CAR T-cell therapy in treating multiple myeloma. Dr. Cooperrider has contributed to several significant publications concerning high-dose cyclophosphamide treatments and maintenance therapies in multiple myeloma and acute myeloid leukemia. Her recent research explores various treatment strategies and outcomes for hematological malignancies, emphasizing measurable residual disease and patient-centered approaches to therapy. With a strong interest in clinical research, she aims to advance treatment protocols and improve patient quality of life through targeted therapeutic strategies.
Department of Philosophy